Pleiotropic effects of statins on brain cells

Biochim Biophys Acta Biomembr. 2020 Sep 1;1862(9):183340. doi: 10.1016/j.bbamem.2020.183340. Epub 2020 May 6.

Abstract

Starting with cholesterol homeostasis, the first part of the review addresses various aspects of cholesterol metabolism in neuronal and glial cells and the mutual crosstalk between the two cell types, particularly the transport of cholesterol from its site of synthesis to its target loci in neuronal cells, discussing the multiple mechanistic aspects and transporter systems involved. Statins are next analyzed from the point of view of their chemical structure and its impingement on their pharmacological properties and permeability through cell membranes and the blood-brain barrier in particular. The following section then discusses the transcriptional effects of statins and the changes they induce in brain cell genes associated with a variety of processes, including cell growth, signaling and trafficking, uptake and synthesis of cholesterol. We review the effects of statins at the cellular level, analyzing their impact on the cholesterol composition of the nerve and glial cell plasmalemma, neurotransmitter receptor mobilization, myelination, dendritic arborization of neurons, synaptic vesicle release, and cell viability. Finally, the role of statins in disease is exemplified by Alzheimer and Parkinson diseases and some forms of epilepsy, both in animal models and in the human form of these pathologies.

Keywords: Blood-brain barrier; Cholesterol; Glia; Neuron; Pleiotropic effects; Statins.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Alzheimer Disease / drug therapy
  • Alzheimer Disease / pathology
  • Brain / metabolism*
  • Brain / pathology
  • Cell Membrane Permeability / drug effects
  • Cholesterol / metabolism*
  • Homeostasis / genetics
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / chemistry*
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Neuroglia / metabolism
  • Neurons / metabolism*
  • Parkinson Disease / drug therapy
  • Parkinson Disease / pathology
  • Synaptic Vesicles / drug effects
  • Synaptic Vesicles / genetics

Substances

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Cholesterol